KRTDAP Inhibitors
KRTDAP inhibitors include a range of compounds that exert their inhibitory effects through various cellular mechanisms, affecting keratinocyte differentiation and survival, both of which are fundamental to the functional activity of KRTDAP. The MAPK/ERK pathway, targeted by compounds like PD98059, is an essential signaling cascade that regulates cellular processes including growth and differentiation. When this pathway is inhibited, the differentiation of keratinocytes can be impaired, which is a critical step in the expression and function of KRTDAP. Similarly, the PI3K/AKT pathway, which is inhibited by LY294002.
Similarly, the PI3K/AKT pathway is another significant signaling pathway that regulates cell survival, growth, and differentiation. LY294002, a PI3K inhibitor, prevents the phosphorylation and activation of AKT. This inhibition can lead to a reduction in the survival signals and proliferation cues that are necessary for the proper differentiation of keratinocytes. As a result, the function of proteins associated with differentiated keratinocytes, such as KRTDAP, may be decreased.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, which decreases deoxyribonucleotide levels, leading to replication stress and potentially hampering the expression of KRTDAP due to a slowdown in the cell cycle, as KRTDAP is typically expressed during keratinocyte differentiation which is tied to cell cycle progression. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent kinase inhibitor that can broadly inhibit protein kinases, leading to the inhibition of signaling pathways that are crucial for cell differentiation and survival. This could indirectly affect KRTDAP, which is associated with keratinocyte differentiation, by halting cellular processes that are upstream of KRTDAP expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression through retinoic acid receptors, influencing keratinocyte proliferation and differentiation. Since KRTDAP is involved in keratinocyte differentiation, the alteration of this process by retinoic acid can lead to decreased KRTDAP activity as keratinocyte differentiation is suppressed. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporine A is an immunosuppressant that inhibits calcineurin. By doing so, it blocks T-cell activation, which can influence skin inflammation and keratinocyte behavior indirectly. Reduced inflammation could lead to less demand for KRTDAP function in stressed keratinocytes. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone is a glucocorticoid that acts as an anti-inflammatory by inhibiting the transcription of pro-inflammatory cytokines. It also influences skin cell proliferation and differentiation, which could result in decreased KRTDAP activity due to the suppression of keratinocyte differentiation signals. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that blocks the MAPK/ERK pathway. Since the MAPK pathway is involved in the regulation of cell growth and differentiation, inhibiting this pathway could impair keratinocyte differentiation, subsequently reducing the expression or function of KRTDAP. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can prevent the activation of AKT, leading to the inhibition of cell survival and proliferation pathways. Impaired keratinocyte survival and proliferation could reduce the need for KRTDAP expression, which is associated with differentiated keratinocytes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. By inhibiting p38 MAPK signaling, it can decrease the production of pro-inflammatory cytokines and influence keratinocyte differentiation. This reduction in differentiation signals can lead to decreased KRTDAP activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has multiple biological effects, including the inhibition of the NF-κB pathway, which plays a role in inflammation and cell survival. As such, curcumin can influence keratinocyte function and potentially reduce the expression of KRTDAP by altering the inflammatory response and differentiation cues in the skin. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide exhibits immunomodulatory properties by inhibiting the production of TNF-alpha. This can alter the inflammatory response and indirectly affect the expression of proteins like KRTDAP associated with keratinocyte differentiation and response to inflammation. | ||||||